Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528566 · ClinicalTrials.gov registry record · NA
Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01528566: Completed NA study, sponsored by University of Arkansas.
NCT01528566 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01528566, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This is the first study to test the effect of Tai Chi on pain from knee osteoarthritis in community-dwelling elders with mild cognitive impairment. If Tai Chi is effective in reducing pain, clinicians can use it routinely with this population; then elders can maintain their functional ability longer, and perhaps delay or prevent long-term care admission, and the investigators can save health care dollars.
Primary Outcome
Measured by 1). the WOMAC pain subscale; 2). the Verbal Descriptor Scale (VDS); 3). Keefe observational method; and 4). Analgesic intake.
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL Tai Chi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT01528566 record still lists
NCT01528566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT01528566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01528566 about?
NCT01528566 is a clinical study titled "Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia". This is the first study to test the effect of Tai Chi on pain from knee osteoarthritis in community-dwelling elders with mild cognitive impairment. If Tai Chi is effective in reducing pain, clinicians can use it routinely with this population; then elders can maintain their functional ability longer...
What is the current status of trial NCT01528566?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2008-01. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01528566?
The interventions under investigation include: Attention control (BEHAVIORAL), Tai Chi (BEHAVIORAL).
Who is sponsoring clinical trial NCT01528566?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01528566's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia